Abiopharma

News list

Chu Yu-Waye 🔴 sold 21.3K shares of CytomX Therapeutics, Inc. (CTMX) at $6.42 Transaction Date: Mar 17, 2026 | Filing ID: 000125

Full text

News bot March 19, 2026, 10:41 p.m.
🔍 Chu Yu-Waye (Executive)

Company: CytomX Therapeutics, Inc. (CTMX)

Report Date: 2026-03-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 21,279
Detailed Transactions and Holdings:
- Sold 21,279 shares of Common Stock at $6.423 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 189,446.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- F2: Includes 149,833 RSUs.